Zolpidemdosage

zolpidem tartrate 10 MG Sublingual Tablet [Edluar]

Dosage and administration

Use the lowest dose effective for the patient

Recommended dose is 5 mg for women and 5 or 10 mg for men, immediately before bedtime.

Geriatric patients and patients with hepatic impairment: Recommended dose is 5 mg for men and women.

Lower doses of CNS depressants may be necessary when taken concomitantly with Edluar.

Co-administration with CNS depressants: Recommended dose is 5 mg for men and women.

The effect of Edluar may be slowed if taken with or immediately after a meal.

Edluar sublingual tablet should be placed under the tongue, where it will disintegrate.

The tablet should not be swallowed and the tablet should not be taken with water.

2.1 Dosage in

Adults Use the lowest effective dose for the patient. The recommended initial dose is 5 mg for women and either 5 or 10 mg for men, taken only once per night immediately before bedtime with at least 7-8 hours remaining before the planned time of awakening. If the 5 mg dose is not effective, the dose can be increased to 10 mg. In some patients, the higher morning blood levels following use of the 10 mg dose increase the risk of next day impairment of driving and other activities that require full alertness. The total dose of Edluar should not exceed 10 mg once daily immediately before bedtime. The recommended initial doses for women and men are different because zolpidem clearance is lower in women.

2.2 Special

Populations Elderly or debilitated patients may be especially sensitive to the effects of zolpidem tartrate. Patients with hepatic insufficiency do not clear the drug as rapidly as normal subjects. The recommended dose of Edluar in both of these patient populations is 5 mg once daily immediately before bedtime.

2.3 Use with CNS

Depressants Dosage adjustment may be necessary when Edluar is combined with other CNS-depressant drugs because of the potentially additive effects.

2.4 Administration

The effect of Edluar may be slowed by ingestion with or immediately after a meal. Edluar sublingual tablet should be placed under the tongue, where it will disintegrate. The tablet should not be swallowed and the tablet should not be taken with water.

Text above is quoted in full from the FDA-approved drug label published by openFDA, effective August 15, 2022. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.

This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.

See what it costs — price without insurance